Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Gene Therapy Focus

Explore the latest updates and expert interviews
Latest Videos Videos by Disease CAR-T Therapy Conferences Features Podcasts

Welcome to the Gene Therapy Focus

Explore the latest in this field by hematological disease type, showcasing expert interviews and discussions, podcasts and more.

The Gene Therapy Channel covers a variety of therapy types, with a focus on CAR-T therapy and other genome-editing techniques, including CRISPR-Cas9.

Videos by Disease

Multiple Myeloma
Lymphoma
Non-Malignant
AML
CLL
ALL
1:24
Richter’s transformation in 2026: where does the field stand and what challenges remain?
Erin Parry • 17 Oct 2026
1:17
Individualized bridging therapy before BCMA-directed CAR T-cell therapy
Jule Cecilia Artzenroth • 24 Sep 2026
2:49
Efficacy and safety of GPRC5D-targeted QLS32015 in multiple myeloma
Jian Cui • 23 Sep 2026
1:09
Overcoming challenges in TCR mapping for personalized immunotherapy in multiple myeloma
David Avigan • 23 Sep 2026
View All Videos
2:24
Key considerations for optimizing treatment sequencing in DLBCL
Gilles Salles • 10 Sep 2026
2:01
Understanding the risks of lymphoproliferative disorders following CAR T-cell therapy
Michael Jain • 11 Sep 2026
1:03
Treatment options for patients with R/R DLBCL who progress after CAR-T and bispecifics
Juan Alderuccio • 11 Sep 2026
0:55
Updates on advances in geriatric assessment and treatment in DLBCL for older patients
Pallawi Torka • 11 Sep 2026
View All Videos
5:45
Importance of long-term surveillance after gene therapy in patients with hemophilia
Radek Kaczmarek • 20 Jul 2026
7:23
Understanding potential malignancy risk following AAV gene therapy in hemophilia
Radek Kaczmarek • 20 Jul 2026
5:18
Ongoing challenges associated with using AAV-based gene therapy in hemophilia
Radek Kaczmarek • 20 Jul 2026
4:58
Emerging non-AAV gene therapy strategies in hemophilia: opportunities and challenges
Radek Kaczmarek • 20 Jul 2026
View All Videos
10:42
SENTI-202: a first-in-class logic-gated off-the-shelf CAR NK-cell therapy for R/R AML
Stephen Strickland • 19 Sep 2026
13:39
AVC-201: a CAR-T using a switchable module in AML
Marion Subklewe • 19 Sep 2026
1:23
Exploring CARM1 as a leukemia-specific stem cell vulnerability whilst retaining normal hematopoiesis
Stephen Nimer • 18 Sep 2026
2:41
MDS & AML highlights from EHA 2026: secondary myeloid malignancies after CAR-T & menin inhibitors
Ibrahim Yakoub-Agha • 12 Jun 2026
View All Videos
1:21
Is there a role for CAR T-cell therapy in the treatment pathway for CLL?
Marco Ruella • 16 Oct 2026
1:51
Insights into the current CLL treatment algorithm and emerging research directions
Matthew Davids • 17 Oct 2026
2:31
Emerging BTK inhibitor combination strategies being explored in CLL
Alexey Danilov • 13 Jun 2026
1:25
Looking towards a cure in CLL
Matthew Davids • 12 Jun 2026
View All Videos
3:52
Avoiding common pitfalls when managing patients with ALL outside of specialist centers
Bijal Shah • 10 Sep 2026
3:18
Targeted therapies and immunotherapy are redefining transplantation in AML
Arnon Nagler • 15 Jun 2026
3:38
Evolving treatment strategies and unmet needs in acute lymphoblastic leukemia
Marlise Luskin • 5 Jun 2026
1:24
The safety & efficacy of cladribine/cyclophosphamide lymphodepletion in CD19 CAR-T therapy for B-ALL
Kriti Gera • 1 Jun 2026
View All Videos

Conferences

IMS 2026
EHA 2026
ASCO 2026
COMy 2026
iwCAR-T 2026
iwMyeloma 2026
1:17
Individualized bridging therapy before BCMA-directed CAR T-cell therapy
Jule Cecilia Artzenroth • 24 Sep 2026
2:49
Efficacy and safety of GPRC5D-targeted QLS32015 in multiple myeloma
Jian Cui • 23 Sep 2026
1:09
Overcoming challenges in TCR mapping for personalized immunotherapy in multiple myeloma
David Avigan • 23 Sep 2026
1:25
Identifying tumor-reactive T-cell clones to guide personalized immunotherapy in multiple myeloma
David Avigan • 23 Sep 2026
View All Videos
2:31
Emerging BTK inhibitor combination strategies being explored in CLL
Alexey Danilov • 13 Jun 2026
6:19
Patterns of infection following next-generation B-cell-depleting immunotherapies for NHL
Lorenzo Nigri • 9 Jun 2026
0:55
Underrecognized post-CAR-T toxicities that are important to monitor in patients with DLBCL
Matthew Frank • 12 Jun 2026
1:21
CD22-directed CAR-T for NHL subtypes: toxicity and sequencing insights
Matthew Frank • 12 Jun 2026
View All Videos
3:37
Managing side effects associated with lymphoma immunotherapies: beyond CRS & ICANS
Joshua Brody • 29 May 2026
4:14
How may purinostat methylate fit into the current treatment landscape for R/R MM and DLBCL?
Lijuan Chen • 30 May 2026
1:47
Pooled analysis data from EPCORE NHL-2: epcoritamab plus platinum salvage in R/R DLBCL
Yasmin Karimi • 1 Jun 2026
2:24
Improving the outcomes of patients with MCL who progress on BTK inhibitors
Manali Kamdar • 30 May 2026
View All Videos
1:52
Bispecifics in myeloma: insights and challenges in a community setting
Heinz Ludwig • 14 May 2026
3:22
Expanding access to bispecific antibodies and CAR T-cell therapy in myeloma
Rakesh Popat • 15 May 2026
1:52
Insights into the potential for a cure in myeloma: MRD negativity & CAR-T therapies
Gösta Gahrton • 15 May 2026
8:13
Key highlights from COMy 2026: quadruplet regimens, CAR-T, bispecifics, trispecifics, and more
Mohamad Mohty • 15 May 2026
View All Videos
12:16
The future of T-cell engagers and CARs in acute lymphoblastic leukemia
Bijal Shahet al. • 25 Apr 2026
12:13
Updates on T-cell engagers and CARs in CLL: liso-cel, novel agents, and resistance mechanisms
Alexey Danilovet al. • 25 Apr 2026
14:46
Cellular therapy approaches in AML: novel targets, off-the-shelf CARs, & NK-cell therapy
David Sallmanet al. • 25 Apr 2026
25:30
Dual-targeting CARs in LBCL: trial updates and discussing the role of bridging therapy
Akil Merchantet al. • 26 Apr 2026
View All Videos
11:43
Immunotherapies in myeloma: novel bispecific data, off-the-shelf CAR-T, and trispecific approaches
Binod Dhakalet al. • 12 Apr 2026
View All Videos

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals